Effectiveness of KAP-based nursing program in managing digestive symptoms in colorectal cancer patients undergoing chemotherapy: A retrospective controlled study.
2/5 보강
OpenAlex 토픽 ·
Nausea and vomiting management
Cancer survivorship and care
Oral health in cancer treatment
ObjectiveTo improve gastrointestinal (GI) symptom clusters in colorectal cancer (CRC) patients undergoing chemotherapy by implementing a nursing program based on Knowledge, Attitudes, and Practice (KA
- 표본수 (n) 150
- p-value P < 0.05
APA
Wenli Chen, Dandan Jiang, et al. (2026). Effectiveness of KAP-based nursing program in managing digestive symptoms in colorectal cancer patients undergoing chemotherapy: A retrospective controlled study.. Technology and health care : official journal of the European Society for Engineering and Medicine, 9287329261432852. https://doi.org/10.1177/09287329261432852
MLA
Wenli Chen, et al.. "Effectiveness of KAP-based nursing program in managing digestive symptoms in colorectal cancer patients undergoing chemotherapy: A retrospective controlled study.." Technology and health care : official journal of the European Society for Engineering and Medicine, 2026, pp. 9287329261432852.
PMID
41891935 ↗
Abstract 한글 요약
ObjectiveTo improve gastrointestinal (GI) symptom clusters in colorectal cancer (CRC) patients undergoing chemotherapy by implementing a nursing program based on Knowledge, Attitudes, and Practice (KAP).MethodsThis retrospective study analyzed the medical records of 292 CRC patients who received chemotherapy from June 2023 to December 2024 in Bozhou Hospital Affiliated to Anhui Medical University. Patients were divided into a control group (CG, n = 150) and an intervention group (IG, n = 142) according to the GI symptom cluster nursing intervention program. GI symptoms, self-management efficacy, level of beliefs, psychological status, functional status, and quality of life were assessed in patients before the intervention (T1), after the fourth chemotherapy session (T2), and after the eighth chemotherapy session (T3).ResultsAt T1, there were no significant differences between the two groups in any of the assessed indices. At T2 and T3, the GI symptom clusters, the number of symptoms, the incidence of symptom clusters, and the nausea, loss of appetite, dry mouth, vomiting, diarrhea, change in appetite, and fullness in the patients of the IG were significantly lower than those of the CG. (P < 0.05). In addition, patients in the IG showed significant improvements in self-management efficacy, belief level, psychological condition, functional status and quality of life (P < 0.05).ConclusionThe KAP-based nursing program is both acceptable and feasible for managing GI symptom clusters in CRC patients undergoing chemotherapy. It effectively improves patients' GI symptoms and enhances their self-management efficacy, belief levels, psychological status, functional status, and quality of life.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (5)
- FcγRIIb deficiency inhibits tumor development by attenuating the immunosuppressive phenotype of MDSCs.
- Oligometastatic Prostate and Bladder Cancer: An Integrative Narrative Review.
- Real world deployment of a pancreatic cancer risk model: impact of refitting, imputation, and computational burden.
- IRF1 suppresses gastric tumorigenesis via dual PI3K/AKT-ERK pathway modulation and functional antagonism of oncogenic MX2.
- Androgen Receptor Signaling Inhibitors for Metastatic Hormone Sensitive Prostate Cancer in Asians: Indirect Comparison.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Impact of Comorbidities on Clinical Outcomes and Quality of Life of Patients With Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative (HR+/HER2-) Advanced Breast Cancer Treated With Palbociclib in the POLARIS Study.
- Key Considerations for Targeting in Pancreatic Cancer: Potential Impact on the Treatment Paradigm.
- Overcoming Chemoresistance in Glioblastoma: Mechanisms, Therapeutic Strategies, and Functional Precision Medicine.
- Current Systemic Treatment Options for Advanced Pancreatic Cancer-An Overview Article.
- A Phase II Study of Durvalumab, Doxorubicin, and Ifosfamide in Recurrent and/or Metastatic Pulmonary Sarcomatoid Carcinoma (KCSG LU-19-24).